[Development of TP53-Targeted Treatment in Esophageal Squamous Cell Carcinoma Using Cancer Genomic Profiling Test].

Kamata, Toshiki; Kano, Masayuki; Takahashi, Masahiko; Murakami, Kentaro; Sakata, Haruhito; Toyozumi, Takeshi; Sekino, Nobufumi; Yokoyama, Masaya; Okada, Koichiro; Shiraishi, Tadashi; Ryuzaki, Takahiro; Matsubara, Hisahiro

Kamata, Toshiki; Kano, Masayuki; Takahashi, Masahiko; Murakami, Kentaro; Sakata, Haruhito; Toyozumi, Takeshi; Sekino, Nobufumi; Yokoyama, Masaya; Okada, Koichiro; Shiraishi, Tadashi; Ryuzaki, Takahiro; Matsubara, Hisahiro.

Affiliation

Kamata T; Dept. of Frontier Surgery, Graduate School of Medicine, Chiba University.

Gan To Kagaku Ryoho ; 46(10): 1608-1610, 2019 Oct.

Article in Ja | MEDLINE | ID: mdl-31631150

Subject(s)

Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Molecular Targeted Therapy; Esophageal Neoplasms/drug therapy; Esophageal Squamous Cell Carcinoma/drug therapy; Genomics; Humans; Mutation; Tumor Suppressor Protein p53

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Molecular Targeted Therapy / Esophageal Squamous Cell Carcinoma Limits: Humans Language: Ja Journal: Gan To Kagaku Ryoho Year: 2019 Type: Article

Search on Google

XML

PubMed Links